Company Five Prime Therapeutics, Inc.
Equities
FPRX
US33830X1046
Biotechnology & Medical Research
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Reese
CEO | Chief Executive Officer | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,341,318 | 45,500,078 ( 96.11 %) | 769,289 ( 1.625 %) | 96.11 % |
Company contact information
Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
94080-7047, South San Francisco
+415 365 5600
http://www.fiveprime.comSector
1st Jan change | Capi. | |
---|---|---|
+18.45% | 123B | |
+14.73% | 107B | |
-4.47% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.34% | 16.23B | |
+2.38% | 13.43B | |
+24.39% | 11.32B |